YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the three months ended 31 March 2021.
First-Quarter Reported Results(1)
Key Figures(1) | Q1 2021 | Growth(2) | ||||
Total revenues | KRW 282.2 billion | -8.3% | ||||
Operating profit | KRW 5.0 billion | -18.0% | ||||
K-IFRS profit after taxation | KRW 17.5 billion | T/P |
(1) | � | Results from continuing operations (Green Cross MS blood bag business has been classified as discontinued operations) |
(2) |
| Results and percentages compare to equivalent 2020 period |
Financial Highlights
About GC Pharma
GC Pharma is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines. Headquartered in South Korea, GC Pharma is the largest plasma protein product manufacturer in Asia and has been dedicated to quality healthcare solutions more than half a century. Green Cross Corporation updates its corporate brand as GC Pharma in early 2018. Green Cross Corporation remains the company’s registered, legal name.
This release includes forward-looking statements, which express the current beliefs and expectations of GC Pharmas management. Such statements speak only as of the date on which they are made and the company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contacts
Investor/Media Contact
HyunGoo Kang
+82 31 260 9382
gookang@greencross.com
WooSub Shin
+82 31 260 9397
isswoo@greencross.com
Yelin Jun
+82 31 270 1505
yelin@greencross.com
JiWoong Kim
+82 31 260 0759
yoholiday@greencross.com
One of the industry’s most coveted ‘Employer-of-Choice’ recognitions, the Best Place to Work Certification reinforces…
PARIS--(BUSINESS WIRE)--Regulatory News: ESI Group (Paris:ESI) has partnered with industry analysts Aberdeen Strategy and Research…
News Highlights: UMC's 3D IC solution for RFSOI reduces circuit footprint by more than 45%,…
SINGAPORE--(BUSINESS WIRE)--The annual general meeting (“AGM”) of Hafnia Limited (“Hafnia”) is scheduled for 14 May…
HANOI, VIETNAM - Media OutReach Newswire - 2 May 2024 - The nomination portal for…
Confluent’s new AI Model Inference seamlessly integrates AI and ML capabilities into data pipelines Confluent…